SK pharmteco to Ensure Supply of Ferring Pharmaceuticals Gene Therapy April 27, 2024 AutoBot News 0 SK pharmteco, a CDMO, will manufacture, test, and release Adstiladrin (nadofaragene firadenovec-vncg), a gene therapy from Ferring Pharmaceuticals for treating bladder cancer.